Nab-PTX Plus S-1 and Sintilimab as Adjuvant Therapy in Patients With Stage IIIC Gastric Cancer
Clinical trial NCT04781413 · UNKNOWN
Trial details
- NCT number
- NCT04781413
- Sponsor
- Ruijin Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-01
- Primary completion
- 2024-03-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.